A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), Leonardo Ferreira, Ph.D., is taking on type 1 diabetes (T1D) with support ...

Type 1 Diabetes directly impacts 1.45 million Americans, according to the CDC, and San Diegans are doing everything they can to support finding a cure. Last year 64,000 adults and children were ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Type 1 diabetes is a lifelong autoimmune condition with no known cure. Unlike type 2 diabetes, which can sometimes be managed or even reversed through lifestyle changes, type 1 diabetes cannot be ...

A dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a revolutionary stem cell treatment, with all but two dropping their insulin ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing. Experts explain ...

A team at Stanford Medicine has delivered something people with Type 1 diabetes have waited decades to hear: a cure in animals that does not rely on toxic chemotherapy or lifelong immune drugs. In ...

CLEVELAND, Ohio. - Living with Type 1 diabetes isn’t just about checking blood sugar and taking insulin. It can lead to serious complications: kidney failure, heart disease, even amputations. But ...

For Alex Davis’ 10-year-old nephew, Hollis, perhaps the most frustrating thing in life right now isn’t the symptoms. It’s often having to turn away treats such as cakes during birthday parties. “From ...

A stem cell trial on a dozen Type 1 diabetes patients suffering from a severe form of the disease has provided at least a temporary cure for 10 participants. The remaining two also dramatically ...

In under eight weeks, SANA has nearly tripled, reflecting a shift from speculative promise to emerging proof-of-concept. If you sized SANA small after the May post, the thesis is tracking; consider ...